Biotechnology Value Fund L P - Mar 31, 2025 SCHEDULE 13G/A Report for Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV)

Filing Manager
Biotechnology Value Fund L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Elevation Oncology, Inc. Common Stock, par value $0.0001 per share
Symbol
ELEV
Shares outstanding
63.4M shares
Disclosed Ownership
4.44M shares
Ownership
7%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 04:27 PM
Date of event
Mar 31, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 3.9% 2.37M 0 2.37M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 3.9% 2.37M 0 2.37M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3% 1.83M 0 1.83M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3% 1.83M 0 1.83M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 210K 0 210K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 210K 0 210K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 6.6% 4.2M 0 4.2M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 7% 4.44M 0 4.44M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 7% 4.44M 0 4.44M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 7% 4.44M 0 4.44M /s/ Mark N. Lampert Mark N. Lampert